JPS6145610B2 - - Google Patents
Info
- Publication number
- JPS6145610B2 JPS6145610B2 JP3655578A JP3655578A JPS6145610B2 JP S6145610 B2 JPS6145610 B2 JP S6145610B2 JP 3655578 A JP3655578 A JP 3655578A JP 3655578 A JP3655578 A JP 3655578A JP S6145610 B2 JPS6145610 B2 JP S6145610B2
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- hbs antigen
- purification
- column
- hbs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000427 antigen Substances 0.000 claims description 55
- 108091007433 antigens Proteins 0.000 claims description 55
- 102000036639 antigens Human genes 0.000 claims description 55
- 238000000034 method Methods 0.000 claims description 26
- 238000000746 purification Methods 0.000 claims description 26
- 210000002966 serum Anatomy 0.000 claims description 8
- 239000007858 starting material Substances 0.000 claims description 7
- 150000001450 anions Chemical class 0.000 claims description 5
- 150000001768 cations Chemical class 0.000 claims description 4
- 238000004255 ion exchange chromatography Methods 0.000 claims 1
- 241000700605 Viruses Species 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 108010017384 Blood Proteins Proteins 0.000 description 7
- 102000004506 Blood Proteins Human genes 0.000 description 7
- 229920002271 DEAE-Sepharose Polymers 0.000 description 7
- 229920005654 Sephadex Polymers 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 229920002684 Sepharose Polymers 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 238000000760 immunoelectrophoresis Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000012507 Sephadex™ Substances 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 108010074605 gamma-Globulins Proteins 0.000 description 5
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 238000000432 density-gradient centrifugation Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 208000002672 hepatitis B Diseases 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005199 ultracentrifugation Methods 0.000 description 3
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000002298 density-gradient ultracentrifugation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005185 salting out Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000012798 spherical particle Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- GJAARPKBDFKHFS-UHFFFAOYSA-N Gerin Natural products COC(=O)C(=C)C1CC2C(=C)C(=O)C=CC2(C)CC1OC(=O)C GJAARPKBDFKHFS-UHFFFAOYSA-N 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000007584 Prealbumin Human genes 0.000 description 1
- 108010071690 Prealbumin Proteins 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 230000000521 hyperimmunizing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- -1 α- 2 -macroglobulin Proteins 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3655578A JPS55304A (en) | 1978-03-31 | 1978-03-31 | Purification of hbs antigen |
| CA312,397A CA1108051A (en) | 1978-03-31 | 1978-09-29 | Method for purification of hbs antigen |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3655578A JPS55304A (en) | 1978-03-31 | 1978-03-31 | Purification of hbs antigen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55304A JPS55304A (en) | 1980-01-05 |
| JPS6145610B2 true JPS6145610B2 (enrdf_load_stackoverflow) | 1986-10-08 |
Family
ID=12472994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3655578A Granted JPS55304A (en) | 1978-03-31 | 1978-03-31 | Purification of hbs antigen |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS55304A (enrdf_load_stackoverflow) |
| CA (1) | CA1108051A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599231A (en) * | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
-
1978
- 1978-03-31 JP JP3655578A patent/JPS55304A/ja active Granted
- 1978-09-29 CA CA312,397A patent/CA1108051A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA1108051A (en) | 1981-09-01 |
| JPS55304A (en) | 1980-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4113712A (en) | HBsAG Particle composed of single polypeptide subunits and the preparation procedure | |
| JPH0231689A (ja) | 百日咳トキシンの精製法 | |
| US4162192A (en) | Method for purification of HBs antigen | |
| EP0011032B1 (en) | Method for isolation of hbsag | |
| JPS6262153B2 (enrdf_load_stackoverflow) | ||
| JP2651307B2 (ja) | 血液凝固ｉｘ因子を含有する複合体 | |
| JPS6136228A (ja) | 肝炎表面抗原の精製方法 | |
| US4883752A (en) | Method for preparing monoclonal antibody to Hbsag | |
| JP2965623B2 (ja) | 精製されたアルブミン溶液の製造方法 | |
| JPH01230600A (ja) | 乳漿からの免疫グロブリンに富む画分の単離 | |
| EP0138167B1 (en) | Method for purification of hbs antigen | |
| JPH0585526B2 (enrdf_load_stackoverflow) | ||
| JPS59176215A (ja) | 静脈内に適用するための副作用のないＩ↓ｇＧ−免疫グロブリン溶液の製法 | |
| WO1981000050A1 (en) | Process for producing hepatitis b vaccine | |
| JPS6145610B2 (enrdf_load_stackoverflow) | ||
| EP0179485B1 (en) | A process for the purification of hbsag | |
| JPS5840930B2 (ja) | Ｂ型肝炎ワクチンの製造方法 | |
| SU728720A3 (ru) | Способ получени вакцины против гепатита в | |
| DE3750330T2 (de) | Verfahren zur Herstellung eines Impfstoffs gegen Hepatitis B. | |
| CA1053151A (en) | Hbsag particle composed of single polypeptide subunits and the preparation procedure | |
| KR100307186B1 (ko) | 한국형씨(c)형간염바이러스의항원결정부위융합단백질인유비엔에스40i12-ii(ubns4e12-ii)의정제방법 | |
| KR100538823B1 (ko) | 비형간염 바이러스 표면항원, 이의 제조방법 및 이를 포함하는 진단용 제제 | |
| JP2721961B2 (ja) | 血液製剤 | |
| JPH0235726B2 (enrdf_load_stackoverflow) | ||
| JPH0574599B2 (enrdf_load_stackoverflow) |